SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004416
Filing Date
2024-02-20
Accepted
2024-02-20 17:15:14
Documents
2
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02202024_050205.html 4  
1 form4-02202024_050205.xml 4 12723
2 ex24-02202024_050205.htm EX-24 3807
  Complete submission text file 0001415889-24-004416.txt   17908
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Michael Robert A. (Reporting) CIK: 0001699914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 24654840